On August 24, GSK announced that its antisense oligonucleotide (ASO) drug Hibsago (bepirovirsen) had been approved by Japan’s Ministry of Health. For the functional cure
November 13, 2026
No Comments
Newsletter
Sign up our newsletter to get update information, news and free insight.